Best ETFs for 2019: The Global X Robotics and AI ETF Is Just OK Right Now

Advertisement

This article is a part of InvestorPlace’s Best ETFs for 2019 contest. Tom Taulli’s pick for the contest is the Global X Robotics & Artificial Intelligence Thematic ETF (NASDAQ:BOTZ).

During the past quarter, the performance of the Global X Robotics & Artificial Intelligence Thematic ETF (NASDAQ:BOTZ), which is my pick for InvestorPlace’s Best ETFs for 2019 contest, has been mixed. The stock did get off to a good start, going from $20.50 to $21.77 within a few weeks. But the correction in the markets took a toll, as BOTZ dropped to $18.80.

Best ETFs for 2019: The Global X Robotics and AI ETF Is Just OK Right Now

And as of now? It’s back to where it started.

And more volatility is expected in the AI/Robotics sector. Just some of the factors that have weighed down on the stocks include: competition, challenges of introducing new products and the U.S.-China trade war, which has disrupted global supply chains.

Despite all this, I’m still bullish on AI/Robotics. These technologies are likely to lead to leaps in progress across many industries. For example, IDC predicts that spending on AI will jump from $24 billion in 2018 to $77.6 billion by 2022 and the spending on robotics/drones will go from $115.7 billion to $210.3 billion.

In light of all this, is it any wonder that the mega tech companies like Microsoft (NASDAQ:MSFT), Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL), Amazon (NASDAQ:AMZN) and Facebook (NASDAQ:FB) consider AI to be strategic? Of course not. In fact, Alphabet’s CEO, Sundar Pichai, says his company is “AI-first.”

So then, what about the BOTZ ETF? Well, it has a portfolio of 37 stocks and the net assets come to about $1.55 billion. The average market cap is $10 billion or so.

As for some of the holdings, here’s a look:

  • Intuitive Surgical (NASDAQ:ISRG): For the quarter, the shares are off about 8%. The company, which is a leader in robotic surgery systems (the flagship product is called da Vinci Surgical), posted a disappointing quarterly report. Yet ISRG is still growing at a solid pace and is getting traction with new Food and Drug Administration approvals. According to InvestorPlace’s Louis Navellier: “Because ISRG is one of the first pioneers in this sector, it has a significant competitive advantage since the barriers to entry are significant and it has built a reputation in a very conservative sector.”
  • Nvidia (NASDAQ:NVDA): When it comes to AI, this company is one of the top players in the industry. Although, since September, NVDA stock has been in an agonizing downtrend, going from $281 to $151. Keep in mind that the company has had to deal with eroding business from the data center as well as the collapse of the crypto-mining category. But of course, NVDA is working hard to turn things around, such as with the $7 billion acquisition for Mellanox Technologies (NASDAQ:MLNX).
  • iRobot Corporation (NASDAQ:IRBT): Yes, it was a tough quarter for the company. The shares have plunged from $119 to $92. Then again, the company reported quarterly results that fell short of Wall Street expectations. But IRBT still has maintained its full-year guidance and is looking for a lift from several new products.

Ultimately, while the BOTZ ETF might not win the best ETFs competition, I still wouldn’t call it a complete loser despite its disappointments.

Tom Taulli is the author of the upcoming book, Artificial Intelligence Basics: A Non-Technical IntroductionFollow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities.

Tom Taulli is the author of various books. They include Artificial Intelligence Basics and the Robotic Process Automation Handbook. His upcoming book is called Generative AI: How ChatGPT and other AI Tools Will Revolutionize Business.


Article printed from InvestorPlace Media, https://investorplace.com/2019/06/best-etfs-for-2019-the-global-x-robotics-and-ai-etf-is-just-ok-right-now/.

©2024 InvestorPlace Media, LLC